Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Neuroton** is a brand name associated with several distinct pharmaceutical and medical products. In clinical research, it most frequently refers to **citicoline** (cytidine-5'-diphosphocholine), a neuroprotective intermediate in the biosynthesis of cell membrane phospholipids. It has been evaluated in randomized clinical trials for its ability to improve retinal function and visual pathway responses in patients with glaucoma and amblyopia. Another widely marketed version of Neuroton (notably by Amoun Pharmaceutical Company) is a **Vitamin B complex** containing Vitamins B1 (thiamine), B6 (pyridoxine), and B12 (cyanocobalamin), which is indicated for the treatment of peripheral neuropathies and nutritional deficiencies. Historically, the name was also applied to **guaifenesin** (guaiacol glyceryl ether) in research regarding its effects on muscle relaxation and animal behavior. Furthermore, the name is used for the **Neuroton-626**, an apparatus designed for the electrodiagnosis of nerve trunk diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Neuroton.